Bacterial Epidemiology and Empirical Antibiotherapy in Patients With Prosthetic Joint Infection
1 other identifier
observational
567
1 country
1
Brief Summary
The purpose of this study is to establish a bacterial epidemiology in patients who present a prosthetic joint infection and for which a surgery is necessary. At the time of the first surgery, as the bacteria responsible for the infection are not known, a probabilistic antibiotherapy is initiated at once after the surgical treatment. The antibiotherapy is then adapted to the bacteria from samples collected during the surgery when they are identified (the delay is 14-21 days). The study will focus on bacteria identified on samples collected during the surgery; the delay between the implantation of the prosthesis and the presentation of symptoms will be considered : more than one year vs. less than one year. Investigators assume that there is not the same type of bacteria involved in those two cases of delays and that the probabilistic antibiotherapy may be not optimal when the symptoms are presented more than one year after implantation of the prosthesis. A probabilistic antibiotherapy not adapted lead to develop resistance for the bacteria and decrease the chance to cure the patient (increasing of relapse). The result of this study will allow medical doctors to have an optimal probabilistic antibiotherapy, depending on the delay between implantation of the prosthesis and the presentation of the symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2016
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
April 21, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2017
CompletedFirst Posted
Study publicly available on registry
June 19, 2017
CompletedAugust 24, 2017
August 1, 2017
11 months
April 21, 2017
August 23, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
identification of bacteria involved in patients with prosthetic joint infection
The samples collected during the surgery are put in bacteriological culture media. Bacteriological culture of samples collected during surgery for all patients included is made allowing to identify which type of bacteria is involved in the infection, depending on the chronology of the infection (delay between implantation and the presentation of the symptoms \[\< 1 year vs. \> 1 year\])
3 weeks after the surgery
collection of probabilistic antibiotic treatment in patients with prosthetic joint infection
The type of molecule used and dosage will be described. Probabilistic antibiotic treatment is initiated immediately after the surgery, before the bacteria is identified. The samples are put in bacteriological culture media. The time to obtain results is usually 3 weeks maximum after the surgery because this is the delay for slow-growing bacteria to grow. Then, the empirical treatment can be amended in order to have an antibiotic treatment adapted to the bacteria found.
the day of surgery
Secondary Outcomes (2)
adverse events
up to 24 months after antibiotic therapy disruption
Treatment failure
up to 24 months after antibiotic therapy disruption
Eligibility Criteria
patient with prosthetic joint infection and treated with probabilistic antibiotherapy after a first surgery
You may qualify if:
- patient with prosthetic joint infection and treated with probabilistic antibiotherapy, between 2010 and 2015, at the Croix-Rousse Hospital
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital de la Croix Rousse
Lyon, 69004, France
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Tristan Ferry, MD
Hospices Civils de Lyon
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 21, 2017
First Posted
June 19, 2017
Study Start
June 1, 2016
Primary Completion
April 30, 2017
Study Completion
April 30, 2017
Last Updated
August 24, 2017
Record last verified: 2017-08